PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Beijing Institute of Hepatology, Beijing Youan Hospital, Capital Medical University, 100069, Beijing, China.\', \'Beijing Engineering Research Center for Precision Medicine and Transformation of Hepatitis and Liver Cancer, Beijing, China.\', \'Beijing Institute of Hepatology, Beijing Youan Hospital, Capital Medical University, 100069, Beijing, China. jin_eagle@sina.com.\', \'Beijing Engineering Research Center for Precision Medicine and Transformation of Hepatitis and Liver Cancer, Beijing, China. jin_eagle@sina.com.\', \'Beijing Institute of Hepatology, Beijing Youan Hospital, Capital Medical University, 100069, Beijing, China. dexichen@ccmu.edu.cn.\', \'Beijing Engineering Research Center for Precision Medicine and Transformation of Hepatitis and Liver Cancer, Beijing, China. dexichen@ccmu.edu.cn.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1038/s41419-020-2636-4
?:doi
?:hasPublicationType
?:journal
  • Cell death & disease
is ?:pmid of
?:pmid
?:pmid
  • 32513989
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • The inhibition of IL-2/IL-2R gives rise to CD8+ T cell and lymphocyte decrease through JAK1-STAT5 in critical patients with COVID-19 pneumonia.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all